You have 9 free searches left this month | for more free features.

Condition

Sjogren's Syndrome (1)

Systemic Lupus Erythematosus (SLE) (1)

Type 1 Diabetes Mellitus (1)

Overall Status

Recruiting (2)

Active, not recruiting (1)

Sign in for free

Phase

phase 2 (3)

Sponsor

Novartis Pharmaceuticals (3)

Collaborator

Intervention

cfz533 (2)

cfz533 placebo (2)

cfz533 (iscalimab) (1)

placebo (1)

vay736 (1)

vay736 placebo (1)

Study Documents

Intervention Type

drug (3)

other (2)

Funder Type

Industry (3)

Study Type

Interventional (3)

iscalimab

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Sjögren's Syndrome Trial in Worldwide (CFZ533 (iscalimab), CFZ533 Placebo)

Recruiting

Sjögren's Syndrome

CFZ533 (iscalimab)
CFZ533 Placebo

Duluth, Georgia
+54 more

Oct 14, 2022

Type 1 Diabetes Trial in Worldwide (CFZ533, Placebo)

Recruiting

Type 1 Diabetes Mellitus

CFZ533
Placebo

Edegem, Antwerpen, Belgium
+16 more

Aug 23, 2022

Systemic Lupus Erythematosus (SLE) Trial in Worldwide (VAY736, VAY736 Placebo, CFZ533)

Active, not recruiting

Systemic Lupus Erythematosus (SLE)

VAY736
+3 more

Ciudad Autonoma de Bs As, Buenos Aires, Argentina
+31 more

Sep 19, 2022